Seeking Alpha


Send Message
View as an RSS Feed
View vireoman's Comments BY TICKER:
Latest  |  Highest rated
  • 4 All-Weather Picks Approaching Support [View instapost]
    Taking comfort in the contrarian signal that there is virtually no interest in CTRX on Seeking Alpha, I'm a buyer at current prices. I've done well with competitor ESRX and see no reason I won't do as well with this company.
    Apr 20 11:22 AM | Likes Like |Link to Comment
  • Alberta considers emissions rules to win support for oil sector [View news story]
    This reminds me of stories out of Texas, where the Perry-types/George W-types consider any regulation as being anti-business. But then they don't have to bear the personal consequences of their inaction.
    Apr 17 08:50 AM | 2 Likes Like |Link to Comment
  • Reuters: Petrobras shelves debt sales in wake of scandals [View news story]
    I'm keeping both, thank you very much.
    Apr 7 08:28 PM | Likes Like |Link to Comment
  • Brazil leads emerging markets higher [View news story]
    CZZ and PBR have worked out nicely, as well. Still, I wouldn't get too comfortable with conditions in Brazil just yet.
    Apr 5 11:43 AM | Likes Like |Link to Comment
  • The world needs to get ready for the next nuclear plant accident [View news story]
    The populace of China and the rest of the world would be extraordinarily better off if China quit burning coal tomorrow and switched entirely to nuclear energy. Far (far!) more people have and will continue to die from the ramifications from coal-usage than will ever be affected by nuclear energy. The China Syndrome was just a movie.
    Apr 4 09:01 PM | 17 Likes Like |Link to Comment
  • More bank downgrades ahead of Q1 results [View news story]
    ....."cut to Outperform from Strong Buy." One of my favorites.
    Apr 3 03:51 PM | 1 Like Like |Link to Comment
  • Could AES Tiete Be Forced To Cut Its Dividend? [View article]
    Thanks for a very informative article, PH. This holding has been a lesson on the perils of investing in Brazil.
    Mar 30 03:15 PM | 1 Like Like |Link to Comment
  • Enbridge: Liquids Powered Growth [View article]
    I'm an investor in Enbridge and also an environmentalist. I am neither "anti-resource" (carbon-absorbing boreal forest is a resource, by the way) nor a member of any lobby. However, given the reality of global-warming and the extraordinary and immediate necessity of weaning the world off carbon-based energy, oil-sands bitumen is a supreme example of short-sighted human behavior.
    Mar 27 09:53 PM | 1 Like Like |Link to Comment
  • Now That Petrobras (PBR) Has Bottomed, How High Could It Go? [View instapost]
    I'm glad I'm not into technicals.
    Mar 22 06:06 PM | Likes Like |Link to Comment
  • Bank Of America: No. 28 For Yellen, No. 1 For Shareholders [View article]
    James, the meltdown happened on George W's watch. And there are many that are of the opinion that the Fed saved us from a prolonged depression. History will have to be the final judge of that.

    Colin, you neglected to mention that today's Bank of America also owns Countrywide.
    Mar 21 04:48 PM | 1 Like Like |Link to Comment
  • Walter Energy -11% premarket on gloomy BofA coal assessment [View news story]
    The govt is *finally* making BABY STEPS in the direction of addressing global warming through funding renewable energy and trying to wean the country off coal. BABY STEPS that won't do nearly enough to change the future for the next generations. And that is still far too much for some among us to handle. No wonder we're screwed.
    Mar 20 09:37 AM | 1 Like Like |Link to Comment
  • Increased scrutiny could raise costs for Enbridge project, Moody's says [View news story]
    Replacement of the pipes will reportedly allow twice the flow of Canadian oil-sands to the US. Some are of the opinion that of all the various forms of carbon-based energy available, oil-sands are right up there with Appalachian coal as ones that should definitely remain in the ground. They're right, of course, although I'm not sure that fighting pipelines is the right way to fight this battle.
    Mar 5 11:51 PM | Likes Like |Link to Comment
  • Still Buying Bank Of America On Any Dips [View article]
    Which of the specific charges levied against BAC or JPM would you characterize as "political extortion?"
    Mar 3 11:16 PM | Likes Like |Link to Comment
  • A Close Look At This Morning's Questcor 8-K [View article]
    OK, let's see if I've got this right: Acthar gel has been around for many decades, thus enabling it to be grandfathered-in for approval by the FDA, and thus avoiding any requirement for clinical trials to prove efficacy. QCOR first purchases this product for a
    relative pittance, and then later purchases the manufacturer of the product, thus acquiring all control and 'knowledge' of the product. Although there are relatively inexpensive synthetic-steroid alternatives to the product, vials (or "viles," per a comment above) are sold for $30K apiece on the premise that there are inexplicable, near-magical properties inherent in the product, apparently as a consequence of its porcine (not reptilian, mind you) origins. It is later discovered that the product contains almost none of the primary, active steroid ingredient that is on the label, but is instead composed primarily of degraded by-products of that steroid. That disclosure isn't a concern to the company, as they indicate they knew it all along (just check the fine print on the label), and so did the FDA. Heck, QCOR doesn't know what it is about their product that helps all of those patients, they don't need to know, and they don't really care. For all they know, it might be the degraded by-products with their porcine origins where the near-magical properties reside.

    Even if you're long QCOR, you have to acknowledge the ideal blueprint for a scam here: a grandfathered-in product/no proof of efficacy required/cheaply buy the product and then the manufacturing process/drastically jack-up the price/although cheap alternatives are available, claim not to know what makes your product work/misleading labeling/enormous insider-selling. How many red flags does an investor need? In an efficient, well-functioning world, the FDA would pull the product and demand clinical trials. In this world, I'm not sure what will happen. If enough attention is drawn to the matter, the FDA will have to do something or risk embarrassment. While the FDA's response is uncertain, what I think is a more predictable outcome is the termination of coverage by insurance companies. Continue paying $30K for degraded by-products of porcine adrenal glands?!! I don't think so.
    Mar 3 07:24 PM | 4 Likes Like |Link to Comment
  • An Early Valuation Of Neuralstem's NSI566 [View article]
    I have a position in CUR, and while I am significantly in the money, I have yet to sell any shares. Obviously, I am hopeful about the future of the company, but what I find missing in this article is all that can go wrong before we all reach the inevitable pot of gold at the end. CUR's methodology is novel, and, thus, the odds of failure are great. Let's not get ahead of ourselves. I was there for the nose-dives of both DNDN and IMUC, and it wasn't fun. Take profits when you can, and prepare for the worst. If it all works out, great. You beat the odds.
    Mar 2 11:09 PM | 2 Likes Like |Link to Comment